Skip to main content

Russell Investments Group, Ltd.

Position in EOLS — Evolus, Inc.

CIK 1692234 Seattle, WA

Position in EOLS

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$276,873
-$159,173 QoQ
Shares Held
67,366
+2.7% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Russell Investments Group, Ltd. holds $291,116,040 across 50 Drug Manufacturers - Specialty & Generic names. EOLS ranks #30 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EOLS

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $276,873 67,366
2025-12-31 $436,046 65,571
2025-09-30 $406,706 66,239
2025-06-30 $1,086,410 117,960
2025-03-31 $1,420,562 118,085
2024-12-31 $1,237,252 112,070
2024-09-30 $1,812,649 111,892
2024-06-30 $1,213,235 111,819
2024-03-31 $1,564,766 111,769
2023-12-31 $1,176,927 111,769
2023-09-30 $1,147,435 125,540
2023-06-30 $741,394 101,980
2023-03-31 $515,078 60,884
2022-12-31 $489,546 65,186
2022-09-30 $524,747 65,186
2022-06-30 $1,065,425 91,847
2022-03-31 $1,030,523 91,847
2021-12-31 $396,354 60,884
2021-09-30 $463,936 60,884
2021-06-30 $770,182 60,884
2021-03-31 $790,883 60,884
2020-12-31 $204,570 60,884
2020-09-30 $238,056 60,884